Altieri Fabio, Grillo Caterina, Maceroni Manola, Chichiarelli Silvia
Department of Biochemical Sciences, A. Rossi Fanelli, University La Sapienza, Rome, Italy.
Antioxid Redox Signal. 2008 May;10(5):891-937. doi: 10.1089/ars.2007.1830.
DNA is subjected to several modifications, resulting from endogenous and exogenous sources. The cell has developed a network of complementary DNA-repair mechanisms, and in the human genome, >130 genes have been found to be involved. Knowledge about the basic mechanisms for DNA repair has revealed an unexpected complexity, with overlapping specificity within the same pathway, as well as extensive functional interactions between proteins involved in repair pathways. Unrepaired or improperly repaired DNA lesions have serious potential consequences for the cell, leading to genomic instability and deregulation of cellular functions. A number of disorders or syndromes, including several cancer predispositions and accelerated aging, are linked to an inherited defect in one of the DNA-repair pathways. Genomic instability, a characteristic of most human malignancies, can also arise from acquired defects in DNA repair, and the specific pathway affected is predictive of types of mutations, tumor drug sensitivity, and treatment outcome. Although DNA repair has received little attention as a determinant of drug sensitivity, emerging knowledge of mutations and polymorphisms in key human DNA-repair genes may provide a rational basis for improved strategies for therapeutic interventions on a number of tumors and degenerative disorders.
DNA会受到内源性和外源性因素导致的多种修饰。细胞已形成了一套互补的DNA修复机制网络,在人类基因组中,已发现超过130个基因参与其中。对DNA修复基本机制的了解揭示了意想不到的复杂性,同一途径内存在重叠的特异性,以及修复途径中涉及的蛋白质之间广泛的功能相互作用。未修复或修复不当的DNA损伤对细胞具有严重的潜在后果,会导致基因组不稳定和细胞功能失调。许多疾病或综合征,包括几种癌症易感性和加速衰老,都与DNA修复途径之一的遗传缺陷有关。基因组不稳定是大多数人类恶性肿瘤的一个特征,也可能源于DNA修复的后天缺陷,而受影响的特定途径可预测突变类型、肿瘤药物敏感性和治疗结果。尽管DNA修复作为药物敏感性的决定因素很少受到关注,但关于关键人类DNA修复基因中的突变和多态性的新知识可能为改进多种肿瘤和退行性疾病的治疗干预策略提供合理依据。